| Tom Xiaolin Tan, MD | |
|
730 W Market St, Lima, OH 45801-4602 | |
| (419) 227-3361 | |
| Not Available |
| Full Name | Tom Xiaolin Tan |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 42 Years |
| Location | 730 W Market St, Lima, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710947114 | NPI | - | NPPES |
| 300117618 | Other | OH | RAILROAD MEDICARE |
| 000000177814 | Other | OH | ANTHEM BCBS |
| 300111996 | Other | OH | RAILROAD MEDICARE |
| 2193791 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 35.069960 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christus Spohn Hospital Corpus Christi | Corpus christi, TX | Hospital |
| Christus Spohn Hospital Alice | Alice, TX | Hospital |
| Christus Spohn Hospital Kleberg | Kingsville, TX | Hospital |
| Laredo Medical Center | Laredo, TX | Hospital |
| Christus Spohn Hospital Beeville | Beeville, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Singleton Associates Pa | 6305731118 | 691 |
| Deliverrad Pllc | 6800150095 | 12 |
News Archive
The generic prescription drug discount program introduced earlier this year by Wal-Mart Stores indicates that "markets are, in fact, capable of providing medicines at affordable prices," Peter Pitts, director of the Center for Medicine in the Public Interest and a former associate commissioner at FDA, writes in a Baltimore Sun opinion piece.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis announced today that the Institute for Molecular Medicine Finland will launch a cell microarray screening research program utilizing the Aushon 2470 Arrayer technology.
Advaxis, Inc., a leader in developing cancer immunotherapies, announced today that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead immunotherapy drug candidate, for the treatment of Stage II-IV invasive cervical cancer.
Research aimed at teasing apart the workings of RNA enzymes eventually may lead to ways of monitoring fat metabolism and might even assist in the search for signs of life on Mars, according to University of Michigan researcher Nils Walter.
› Verified 7 days ago
| Entity Name | Singleton Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538107875 PECOS PAC ID: 6305731118 Enrollment ID: O20040315000385 |
News Archive
The generic prescription drug discount program introduced earlier this year by Wal-Mart Stores indicates that "markets are, in fact, capable of providing medicines at affordable prices," Peter Pitts, director of the Center for Medicine in the Public Interest and a former associate commissioner at FDA, writes in a Baltimore Sun opinion piece.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis announced today that the Institute for Molecular Medicine Finland will launch a cell microarray screening research program utilizing the Aushon 2470 Arrayer technology.
Advaxis, Inc., a leader in developing cancer immunotherapies, announced today that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead immunotherapy drug candidate, for the treatment of Stage II-IV invasive cervical cancer.
Research aimed at teasing apart the workings of RNA enzymes eventually may lead to ways of monitoring fat metabolism and might even assist in the search for signs of life on Mars, according to University of Michigan researcher Nils Walter.
› Verified 7 days ago
| Entity Name | Radiology & Imaging Of South Texas Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184669897 PECOS PAC ID: 5890693170 Enrollment ID: O20040929000786 |
News Archive
The generic prescription drug discount program introduced earlier this year by Wal-Mart Stores indicates that "markets are, in fact, capable of providing medicines at affordable prices," Peter Pitts, director of the Center for Medicine in the Public Interest and a former associate commissioner at FDA, writes in a Baltimore Sun opinion piece.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis announced today that the Institute for Molecular Medicine Finland will launch a cell microarray screening research program utilizing the Aushon 2470 Arrayer technology.
Advaxis, Inc., a leader in developing cancer immunotherapies, announced today that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead immunotherapy drug candidate, for the treatment of Stage II-IV invasive cervical cancer.
Research aimed at teasing apart the workings of RNA enzymes eventually may lead to ways of monitoring fat metabolism and might even assist in the search for signs of life on Mars, according to University of Michigan researcher Nils Walter.
› Verified 7 days ago
| Entity Name | Deliverrad Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316449234 PECOS PAC ID: 6800150095 Enrollment ID: O20180516002683 |
News Archive
The generic prescription drug discount program introduced earlier this year by Wal-Mart Stores indicates that "markets are, in fact, capable of providing medicines at affordable prices," Peter Pitts, director of the Center for Medicine in the Public Interest and a former associate commissioner at FDA, writes in a Baltimore Sun opinion piece.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis announced today that the Institute for Molecular Medicine Finland will launch a cell microarray screening research program utilizing the Aushon 2470 Arrayer technology.
Advaxis, Inc., a leader in developing cancer immunotherapies, announced today that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead immunotherapy drug candidate, for the treatment of Stage II-IV invasive cervical cancer.
Research aimed at teasing apart the workings of RNA enzymes eventually may lead to ways of monitoring fat metabolism and might even assist in the search for signs of life on Mars, according to University of Michigan researcher Nils Walter.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tom Xiaolin Tan, MD Po Box 5128, Lima, OH 45802-5128 Ph: (419) 224-5707 | Tom Xiaolin Tan, MD 730 W Market St, Lima, OH 45801-4602 Ph: (419) 227-3361 |
News Archive
The generic prescription drug discount program introduced earlier this year by Wal-Mart Stores indicates that "markets are, in fact, capable of providing medicines at affordable prices," Peter Pitts, director of the Center for Medicine in the Public Interest and a former associate commissioner at FDA, writes in a Baltimore Sun opinion piece.
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis announced today that the Institute for Molecular Medicine Finland will launch a cell microarray screening research program utilizing the Aushon 2470 Arrayer technology.
Advaxis, Inc., a leader in developing cancer immunotherapies, announced today that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead immunotherapy drug candidate, for the treatment of Stage II-IV invasive cervical cancer.
Research aimed at teasing apart the workings of RNA enzymes eventually may lead to ways of monitoring fat metabolism and might even assist in the search for signs of life on Mars, according to University of Michigan researcher Nils Walter.
› Verified 7 days ago
Dr. Sandra J Herrington, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 803 W Market St, Suite 100, Lima, OH 45805 Phone: 419-996-5063 Fax: 419-996-5502 | |
Patricia Lynn Mccutchan, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 730 W Market St, Lima, OH 45801 Phone: 419-227-3361 | |
Peter G Knabe, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 730 W Market St, Lima, OH 45801 Phone: 419-226-9023 Fax: 419-866-5453 | |
Dr. Jeffrey Alan Miller, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 730 W Market St, Lima, OH 45801 Phone: 419-226-9023 Fax: 419-866-5453 | |
Alan Peter Schlesinger, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1001 Bellefontaine Avenue, Fsh Radiology, Inc., Lima, OH 45804 Phone: 419-228-3335 Fax: 419-226-5064 | |
Dr. Michael Jason Bishop, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 803 W Market St Ste 100, Lima, OH 45805 Phone: 419-996-5063 Fax: 419-996-5502 | |
Andrew Peter Cook, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 730 W Market St, Lima, OH 45801 Phone: 419-227-3361 |